634 related articles for article (PubMed ID: 12656645)
1. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.
Kurz A; Sessler DI
Drugs; 2003; 63(7):649-71. PubMed ID: 12656645
[TBL] [Abstract][Full Text] [Related]
2. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
3. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
Holzer P
Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
[TBL] [Abstract][Full Text] [Related]
4. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
Neyens R; Jackson KC
J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725
[TBL] [Abstract][Full Text] [Related]
5. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
Yuan CS
Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
[TBL] [Abstract][Full Text] [Related]
7. Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.
Ali SZ; Kurz A
Expert Rev Pharmacoecon Outcomes Res; 2004 Apr; 4(2):153-7. PubMed ID: 19807518
[TBL] [Abstract][Full Text] [Related]
8. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
Webster L; Jansen JP; Peppin J; Lasko B; Irving G; Morlion B; Snidow J; Pierce A; Mortensen E; Kleoudis C; Carter E
Pain; 2008 Jul; 137(2):428-440. PubMed ID: 18164818
[TBL] [Abstract][Full Text] [Related]
9. Incidence, prevalence, and management of opioid bowel dysfunction.
Pappagallo M
Am J Surg; 2001 Nov; 182(5A Suppl):11S-18S. PubMed ID: 11755892
[TBL] [Abstract][Full Text] [Related]
10. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
11. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
Becker G; Blum HE
Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
[TBL] [Abstract][Full Text] [Related]
12. Mu-opioid antagonists for opioid-induced bowel dysfunction.
McNicol ED; Boyce D; Schumann R; Carr DB
Cochrane Database Syst Rev; 2008 Apr; (2):CD006332. PubMed ID: 18425947
[TBL] [Abstract][Full Text] [Related]
13. Treatment of opioid-induced gut dysfunction.
Holzer P
Expert Opin Investig Drugs; 2007 Feb; 16(2):181-94. PubMed ID: 17243938
[TBL] [Abstract][Full Text] [Related]
14. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
Yuan CS; Israel RJ
Expert Opin Investig Drugs; 2006 May; 15(5):541-52. PubMed ID: 16634692
[TBL] [Abstract][Full Text] [Related]
15. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
16. Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone.
Garten L; Degenhardt P; Bührer C
J Pediatr Surg; 2011 Mar; 46(3):e13-5. PubMed ID: 21376180
[TBL] [Abstract][Full Text] [Related]
17. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature.
Schwenk ES; Grant AE; Torjman MC; McNulty SE; Baratta JL; Viscusi ER
Reg Anesth Pain Med; 2017; 42(6):767-777. PubMed ID: 29016552
[TBL] [Abstract][Full Text] [Related]
19. Alvimopan.
Neary P; Delaney CP
Expert Opin Investig Drugs; 2005 Apr; 14(4):479-88. PubMed ID: 15882122
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION).
Patel PB; Brett SJ; O'Callaghan D; Anjum A; Cross M; Warwick J; Gordon AC
BMJ Open; 2016 Jul; 6(7):e011750. PubMed ID: 27412108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
